DANIEL M. SCHMITT - 13 Feb 2026 Form 4 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)

Role
President, CEO and Director, Director
Signature
/s/ Paul Lytle, Attorney-in-Fact
Issuer symbol
ACTU
Transactions as of
13 Feb 2026
Net transactions value
-$527,714
Form type
4
Filing time
13 Feb 2026, 18:10:04 UTC
Previous filing
02 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SCHMITT DANIEL M President, CEO and Director, Director C/O ACTUATE THERAPEUTICS, INC., 1751 RIVER RUN, SUITE 400, FORT WORTH /s/ Paul Lytle, Attorney-in-Fact 13 Feb 2026 0001318470

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACTU Common Stock Options Exercise $0 +272,055 $0.000000 272,055 13 Feb 2026 Direct F3, F4
transaction ACTU Common Stock Tax liability $527,714 -121,874 -45% $4.33 150,181 13 Feb 2026 Direct F1, F2
holding ACTU Common Stock 564,071 13 Feb 2026 By The Schmitt Family Irrevocable Trust, dated December 31, 2019 F6
holding ACTU Common Stock 22,223 13 Feb 2026 By The Andrew Schmitt Irrevocable Trust, dated December 31, 2019 F7
holding ACTU Common Stock 22,223 13 Feb 2026 By The Anna Schmitt Irrevocable Trust, dated December 31, 2019 F8
holding ACTU Common Stock 22,223 13 Feb 2026 By The Edward Schmitt Irrevocable Trust, dated December 31, 2019 F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACTU Restricted Stock Units Options Exercise $0 -272,055 -50% $0.000000 272,056 13 Feb 2026 Common Stock 272,055 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 121,874 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units ("RSUs").
F2 Represents the closing price of Issuer's common stock on February 13, 2026.
F3 Represents the issuance of 272,055 shares of common stock from the vesting and settlement of 272,055 RSUs, which number excludes the withholding of 121,874 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1).
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vest on August 14, 2026.
F6 Represents shares held by The Schmitt Family Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee (the "Schmitt Family Trust").
F7 Represents shares held by The Andrew Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
F8 Represents shares held by The Anna Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
F9 Represents shares held by The Edward Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.